Data_Sheet_1_Jia-Ji Electro-Acupuncture Improves Locomotor Function With Spinal Cord Injury by Regulation of Autophagy Flux and Inhibition of Necroptosis.PDF by Yin Hongna (10019054)

Image 3_DH2-dependent trans-acting siRNAs regulate leaf and lemma development in rice.tif by Jun Tang (32983)

Data Sheet 1_PM2.5 exposure reprograms cell cycle dynamics in uterine immune cells at single-cell resolution.docx by Lin Zhang (8926)

Reducing nitrogen inputs mitigate <i>Spartina</i> invasion in the Yangtze estuary by Xiao Xu (9506213)

The metoclopramide-induced reestablishment of PRL synthesis in infected mice prevents thymus atrophy. by Ailin Lepletier (328461)

“…*p<0.05; **p<0.01, ***p<0.001.</p>…”

CBF-1 suppresses WC-independent <i>frq</i> transcription by promoting the recruitment of the transcriptional co-repressor RCM-1. by Xuemei Cao (331331)

“…<p>(A, B) ChIP assays showing the enrichment of A) WC-1 and B) WC-2 is decreased and the peak of WC-1 binding is delayed in the <i>cbf-1</i>^<i>KO</i> strain compared to the wild-type strain. …”

C−O Coupling of LPt^IVMe(OH)X Complexes in Water (X = ¹⁸OH, OH, OMe; L = di(2-pyridyl)methane sulfonate) by Julia R. Khusnutdinova (1619044)

Assessment of liver pathology in C57BL/6 mice at the end of 4 weeks of normal protein diet (NPD, control diet) or low protein diet (LPD, malnutrition diet) feeding during the first... by Prasad S. Dalvi (405608)

“…The liver triglyceride levels in the LPD-fed mice were significantly decreased post-recovery as compared with the malnutrition period (All data are presented as means ± SD, n ≥ 4 mice per group, *<i>P</i> < 0.05, ***<i>P</i><0.001, ^†††<i>P</i> < 0.001 vs. …”

Table_1_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.xlsx by Ryousuke Kasai (14577584)

“…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”

DataSheet_1_GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis.pdf by Xiaomiao Ye (13850284)

“…Moreover, compared with WT mice, GSDMD^-/- mice showed reduced infarct size (25.45 ± 3.07% versus 36.47 ± 3.72%), improved left ventricular ejection fraction (37.71 ± 1.81% versus 29.44 ± 2.28%) and left ventricular fractional shortening (18.01 ± 0.97% versus 13.62 ± 1.15%) as well as attenuated pathological damage after I/R injury, along with reduced levels of proinflammatory cytokines and decreased infiltration of neutrophils.…”

Image_3_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

“…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”

Image_6_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

“…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”

Image_2_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

“…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”

Image_1_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

“…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”

Image_5_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

“…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”

Image_4_Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.jpeg by Ryousuke Kasai (14577584)

“…Furthermore, three months following the second immunization, the proportion of high responders among patients with MDs decreased significantly compared to that among patients without MDs (p-value of less than 0.01). …”

Image_8.tif by Angelica Martins Batista (5086820)

“…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”

Image_1.tif by Angelica Martins Batista (5086820)

“…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”

Image_5.tif by Angelica Martins Batista (5086820)

“…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”

Image_3.tif by Angelica Martins Batista (5086820)

“…After logistic regression analysis with adjustment for the covariates gender and ethnicity, CCL5 −403 (rs2107538) CT heterozygotes (OR = 0.5, P-value = 0.04) and T carriers (OR = 0.5, P-value = 0.01) were associated with protection against CCC. …”